Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Convexity Scientific Receives FDA Clearance For Its FLYP™ Nebulizer, Unveils The New Device At Medtrade Spring

Convexity Scientific
Posted on: 27 Mar 18
Convexity Scientific Receives FDA Clearance For Its FLYP™ Nebulizer, Unveils The New Device At Medtrade Spring LIGHTWEIGHT, POCKET-PORTABLE NEBULIZER POISED TO LEAD THE NEXT GENERATION IN RESPIRATORY DISEASE CARE AND TREATMENT

PR Newswire

LAS VEGAS, March 27, 2018

LAS VEGAS, March 27, 2018 /PRNewswire/ -- Following its FDA clearance in May 2017, today, Convexity Scientific (Booth #777), a medtech company committed to innovative design and distribution strategies, unveiled its FLYP™ nebulizer, a game-changing handheld nebulizer that is poised to disrupt how physicians treat pulmonary conditions such as asthma and COPD.

"FLYP is literally breathing new life into the nebulizer market by offering physicians a solution that puts convenience, portability and busy lifestyles at the forefront of how they treat patients with debilitating respiratory conditions, without compromising efficacy or patient outcomes," said Jim Daniels, CEO of Convexity Scientific. He added, "We founded Convexity to conceive of and develop next generation medical devices with patients' lifestyles in mind and we look forward to sharing our first innovation, the FLYP nebulizer, with thousands of top healthcare providers and industry leaders at Medtrade Spring."

Smaller and lighter than a smartphone, FLYP is a pocket-portable and virtually silent nebulizer that can be used at home or in a healthcare facility. The "all-in-one" design means that there are no tubes or control units—users just fill, click, breathe.

"For patients suffering from asthma, COPD and other lung-related diseases, FLYP offers a convenient and effective alternative to preventing and managing flare-ups," said Dr. Ralph Finger, Co-Founder and Chairman of Convexity Scientific and inventor of FLYP. "For years, the patient has been asked to fit their life to their nebulizer. Now with FLYP, there's a nebulizer that fits into their life."

With HypersoniQ™ technology, FLYP utilizes an internal disk that vibrates at an ultrasonic speed. When medication passes through the disk's holes, it produces an inhalable aerosol mist, delivering medication deep into the lungs where it is most effective. Because the disk vibrates 110,000 times per second, the time it takes to dispense the medication is significantly shortened to about seven minutes for most medications.

Powered by a USB rechargeable lithium-ion battery that lasts 10 treatments between recharging, FLYP allows patients to stop wasting time and money on disposable batteries.  FLYP optimizes portability and usability, which may result in increased compliance to recommended treatment schedules.

FLYP is available at flypnebulizer.com for $249.99.

About Convexity Scientific  
Convexity Scientific Inc. is a Fairfield, Connecticut-based medical technology company that is developing the next generation of devices with patients' lifestyles in mind. The company's first medical device, the FLYP™ handheld nebulizer for respiratory diseases, demonstrates Convexity's commitment to transforming medical devices with radical reinventions. FLYP is FDA cleared to treat patients ages 13 and up. For more, go to http://www.flypnebulizer.com.

Press Contacts:
Will Obre
Kwittken
FLYP@Kwittken.com 
646 747 7154

View original content with multimedia:http://www.prnewswire.com/news-releases/convexity-scientific-receives-fda-clearance-for-its-flyp-nebulizer-unveils-the-new-device-at-medtrade-spring-300619953.html

SOURCE Convexity Scientific

PR Newswire
www.prnewswire.com

Last updated on: 27/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.